Psychopharmacology for Mental Health Professionals is organized by PESI HealthCare and will be held on Aug 21, 2018 at DoubleTree by Hilton Chattanooga Downtown, Chattanooga, Tennessee, United States of America.
The target audience for this medical event is Counselors, Psychotherapists, Psychologists, Social Workers, Nurse Practitioners Case Managers, Marriage & Family Therapists, Addiction Counselors, Nurses, Clinical Nurse Specialists, Pharmacists, School Psychologists, Other Mental Health Professionals. This CME Conference has been approved for a maximum of 6.3 clock hours.
Conference Description :
Most clients with DSM-5 diagnoses are being treated with a combination of psychological and pharmacological treatments. Newer drugs are being developed to treat mental disorders based on a better understanding of neurobiological contributions to mental disorders and the latest pharmacological research. To provide appropriate services, you are expected to have a thorough understanding of these common and complex issues. As a mental health professional, keeping up-to-date is essential.
This seminar will update and increase your knowledge of :
• Neurobiological underpinnings of major DSM-5 diagnoses
• Effects and side effects of drugs used to treat these diagnoses
• Responsibilities of the non-prescribing therapist to clients taking psychiatric medication
Specifics of the pharmacological treatment and drugs of choice for Depressive, Bipolar, Schizophrenia Spectrum, Anxiety, OCD, Sleep-Wake, ADHD and Neurocognitive disorders will be presented. Unique to this seminar is information on the common types of psychotherapeutic drugs and other drugs that are abused, and methods for prevention and early detection. Throughout the day, representative case studies will generate discussion and examination of the latest drug treatment for DSM-5 disorders. You will leave this seminar with knowledge and confidence regarding effective and safe application of pharmacological drugs.
Conference Objectives are :
• Explain the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.
• Define the role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.
• Describe the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.
• Compare the effects and side effects of various psychotropic medications, including antipsychotics, antidepressants, benzodiazepines and anticonvulsants.
• Discuss the abuse liability of drugs used in the treatment of anxiety, insomnia, pain and ADHD.
• Describe methods for prevention and early identification of prescription drug abuse among clients.